Linda E Scheffers1, Linda E M Vd Berg1,2, Gamida Ismailova2, Karolijn Dulfer3, Johanna J M Takkenberg4, Wim A Helbing1. 1. Department of Pediatric Cardiology, Erasmus MC-Sophia Children's Hospital, The Netherlands. 2. Center for Lysosomal and Metabolic Diseases, Erasmus MC, The Netherlands. 3. Department of Pediatrics and Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, The Netherlands. 4. Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, The Netherlands.
Abstract
BACKGROUND: Patients with a Fontan circulation have a reduced exercise capacity, which is an important prognostic predictor of morbidity and mortality. A way to increase exercise capacity in Fontan patients might be exercise training. This systematic review assesses the effects of exercise training investigated in Fontan patients in order to provide an overview of current insights. DESIGN AND METHODS: Studies evaluating an exercise training intervention in Fontan patients published up to February 2020 were included in this systematic review. RESULTS: From 3000 potential studies, 16 studies reported in 22 publications met the inclusion criteria. In total, 264 Fontan patients with mean age range 8.7-31 years, were included. Different training types including inspiratory muscle training, resistance training and aerobic training were investigated. Main outcome measures reported were peak oxygen uptake, cardiac function, lung function, physical activity levels and quality of life. Peak oxygen uptake increased significantly in 56% of the studies after training with an overall mean increase of +1.72 ml/kg/min (+6.3%). None of the studies reported negative outcome measures related to the exercise programme. In four studies an adverse event was reported, most likely unrelated to the training intervention. CONCLUSIONS: Exercise training in Fontan patients is most likely safe and has positive effects on exercise capacity, cardiac function and quality of life. Therefore exercise training in Fontan patients should be encouraged. Further studies are required to assess the optimal training type, intensity, duration and long-term effects. Published on behalf of the European Society of Cardiology. All rights reserved.
BACKGROUND: Patients with a Fontan circulation have a reduced exercise capacity, which is an important prognostic predictor of morbidity and mortality. A way to increase exercise capacity in Fontan patients might be exercise training. This systematic review assesses the effects of exercise training investigated in Fontan patients in order to provide an overview of current insights. DESIGN AND METHODS: Studies evaluating an exercise training intervention in Fontan patients published up to February 2020 were included in this systematic review. RESULTS: From 3000 potential studies, 16 studies reported in 22 publications met the inclusion criteria. In total, 264 Fontan patients with mean age range 8.7-31 years, were included. Different training types including inspiratory muscle training, resistance training and aerobic training were investigated. Main outcome measures reported were peak oxygen uptake, cardiac function, lung function, physical activity levels and quality of life. Peak oxygen uptake increased significantly in 56% of the studies after training with an overall mean increase of +1.72 ml/kg/min (+6.3%). None of the studies reported negative outcome measures related to the exercise programme. In four studies an adverse event was reported, most likely unrelated to the training intervention. CONCLUSIONS: Exercise training in Fontan patients is most likely safe and has positive effects on exercise capacity, cardiac function and quality of life. Therefore exercise training in Fontan patients should be encouraged. Further studies are required to assess the optimal training type, intensity, duration and long-term effects. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: C Paech; R A Gebauer; M Weidenbach; A Michaelis; S Mensch; J Weickmann; F Markel; A Koch; I Dähnert; G Seidel; A Seidel; P Rüdrich; B Wolfarth; J Wüstenfeld Journal: Pediatr Cardiol Date: 2022-07-19 Impact factor: 1.838
Authors: Marco Alfonso Perrone; Elettra Pomiato; Rosalinda Palmieri; Giulia Di Già; Fiorella Piemonte; Ottavia Porzio; Maria Giulia Gagliardi Journal: J Cardiovasc Dev Dis Date: 2022-05-27
Authors: Derek L Tran; Hannah Gibson; Andrew J Maiorana; Charlotte E Verrall; David W Baker; Melanie Clode; David R Lubans; Diana Zannino; Andrew Bullock; Suzie Ferrie; Julie Briody; Peter Simm; Vishva Wijesekera; Michelle D'Almeida; Sally E Gosbell; Glen M Davis; Robert Weintraub; Anthony C Keech; Rajesh Puranik; Martin Ugander; Robert Justo; Dominica Zentner; Avik Majumdar; Leeanne Grigg; Jeff S Coombes; Yves d'Udekem; Norman R Morris; Julian Ayer; David S Celermajer; Rachael Cordina Journal: Front Pediatr Date: 2022-01-06 Impact factor: 3.418
Authors: Stefan Dirks; Peter Kramer; Anastasia Schleiger; Hans-Martin Speck; Bernd Wolfarth; Thomas Thouet; Felix Berger; Hannes Sallmon; Stanislav Ovroutski Journal: Front Cardiovasc Med Date: 2022-02-07
Authors: Linda E Scheffers; Willem A Helbing; Elisabeth M W J Utens; Gwen C Dieleman; Karolijn Dulfer; Josefien Noske; Eline A van den Broek; Sylvia Walet; Joanne F Olieman; Johanna C Escher; Marielle W Pijnenburg; Ans T van der Ploeg; Linda E van den Berg Journal: Front Pediatr Date: 2022-01-13 Impact factor: 3.569